News

Parkinson’s Disease Therapeutic Domain Projected to See Transformational Growth Across the 7MM During the Study Period (2020–2034) | DelveInsight
DelveInsight’s analysis forecasts Parkinson’s disease market growth due to the introduction of emerging therapies, expecting a rise in market size during the study period (2020–2034). The anticipated ...
Mid-Day3d
Dubai Parkinson’s Patient Able to Fast for Ramadan After 13 Years, Says Will of His Life! Thanks to Groundbreaking Parkinson’s Pump
This milestone is a testament to King’s College Hospital Dubai’s unwavering dedication to offering groundbreaking, patient-centered care.
New drug for Parkinson’s shown to be effective in clinical trials: 'Very encouraged'
A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...
Arab Times5d
First-of-its-kind treatment offers a new lease on life for the youngest Parkinson’s patient in the UAE and MENA region.
As one of the leading facilities for advanced neurological and Parkinson’s care in the region, King’s College Hospital Dubai ...
The Independent6d
New hope as surprising Parkinson’s treatment deemed safe in clinical trials
The first-line treatment for Parkinson’s is levodopa, which helps increase the levels of dopamine in the brain. However, the ...
BioVie, Inc.: BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson's Disease with First Patient Enrolled
SUNRISE-PD evaluating the Company's anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson's disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one ...
BioPharma Dive6d
New research kindles excitement around stem cell therapies for Parkinson’s
Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...
Hosted on MSN6d
Stem cell therapies for Parkinson’s deemed safe in clinical trials
The first-line treatment for Parkinson’s is levodopa, which helps increase the levels of dopamine in the brain. However, the ...
BioVie initiates SUNRISE-PD trial assessing Bezisterim
BioVie (BIVI) announced that patient enrollment is now open for the Phase 2 SUNRISE-PD clinical trial evaluating the safety and efficacy of ...